Read a synopsis of the challenges and opportunities identified during this webinar, access a recording of the event and all presentations.
Disease specific information
- Epilepsy – COVID-19 & Epilepsy Information International Bureau for Epilepsy (IBE)
- MS – Coronavirus disease (COVID-19) and MS European Multiple Sclerosis Platform (EMSP)
- Stroke – Covid-19 Updates Stroke Alliance for Europe (SAFE)
- Migraine – Migraine & COVID-19 FAQ Migraine Association of Ireland (MAI)
- Brain tumour – COVID-19 Information The International Brain Tumour Alliance (IBTA)
- Parkinson’s Disease – Important information about COVID-19 European Parkinson’s Disease Association (EPDA)
- Myasthenia Gravis – Guidance for the management of Myasthenia Gravis (MG) during the COVID-19 pandemic European Association of Myasthenia Gravis Patients’ Associations (EUMGA)
- Ataxia – Implications of coronavirus (covid-19) for people with ataxia Ataxia UK
- Dystonia – Dystonia without botulinum toxin (COVID-19) Dystonia Europe
- ADHD – ADHD Europe: Guidelines ADHD Management & Support ADHD Europe
- Tourette Syndrome – What if… A practical guide to possible problems Katie Skinner (Specialist Teacher SEMH) via Tourettes Action UK
If your organisation has resources / disease-specific information to share,
please let us know.
|
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
. |
Other resources
|
